Gavin Bennett

3.3k citations

36 papers · 2.6k indexed · 1 hit paper · h-index 15

Impact in

Developmental Neuroscience top 0.5%
- Neurogenesis and neuroplasticity mechanisms
Cellular and Molecular Neuroscience top 1%
- Nerve injury and regeneration
- Axon Guidance and Neuronal Signaling

Papers in ⓘ

Cellular and Molecular Neuroscience 13
- Axon Guidance and Neuronal Signaling 9
Radiology, Nuclear Medicine and Imaging 15
- Monoclonal and Polyclonal Antibodies Research 15

Co-authors: Lawrence Moon (1 shared paper)Reena J. Popat (1 shared paper)Stephen B. McMahon (1 shared paper)Elizabeth J. Bradbury (1 shared paper)James W. Fawcett (1 shared paper)Von R. King (1 shared paper)Susan D. Brain (5 shared papers)Katerine Van Rietschoten (10 shared papers)
Journals: Cancer Research (11 papers)Molecular Cancer Therapeutics (5 papers)Journal of Clinical Oncology (4 papers)Bioanalysis (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: United Kingdom United States Belgium

In The Last Decade

Gavin Bennett

31 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Chondroitinase ABC promotes functional recovery after spinal cord injury 2002 · 1.9k citations

Peers

Countries citing papers authored by Gavin Bennett

Since Specialization

Citations

This map shows the geographic impact of Gavin Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Bennett more than expected).

Fields of papers citing papers by Gavin Bennett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Bennett. The network helps show where Gavin Bennett may publish in the future.

Co-authors

The 25 scholars most cited alongside Gavin Bennett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gavin Bennett Line = papers co-authored together Gavin Bennett links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Chondroitinase ABC promotes functional recovery after spinal cord injury Nature ·Elizabeth J. Bradbury, Lawrence Moon, Reena J. Popat, Von R. King, Gavin Bennett, Preena N. Patel, James W. Fawcett, Stephen B. McMahon Hit paper breakdown →	2002	1866
2	A Rapid and Transient Peripheral Inflammatory Response Precedes Brain Inflammation after Experimental Stroke Journal of Cerebral Blood Flow & Metabolism ·Katie Chapman, Verity Q. Dale, Ádám Dénes, Gavin Bennett, Nancy J. Rothwell, Stuart M. Allan, Barry W. McColl	2009	111
3	Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils Pain ·Gavin Bennett, Sabah Al‐Rashed, S. J.R. Hoult, Susan D. Brain	1998	98
4	MMAE Delivery Using the Bicycle Toxin Conjugate BT5528 Molecular Cancer Therapeutics ·Gavin Bennett, Amy Brown, Gemma Mudd, Philip Huxley, Katerine Van Rietschoten, Silvia Pavan, Liuhong Chen, Sophie Watcham, Johanna Lahdenranta, Nicholas Keen	2020	77
5	Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic Payloads Journal of Medicinal Chemistry ·Gemma Mudd, Amy Brown, Liuhong Chen, Katerine Van Rietschoten, Sophie Watcham, Daniel P. Teufel, Silvia Pavan, Rachid Lani, Philip Huxley, Gavin Bennett	2020	55
6	Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors Cancer Research ·Matthias Eder, Silvia Pavan, Ulrike Bauder‐Wüst, Katerine Van Rietschoten, Ann-Christin Baranski, Helen Harrison, Spencer Campbell, Catherine Stace, Edward H. Walker, Liuhong Chen, Gavin Bennett, Gemma Mudd, Ursula Schierbaum, Karin Leotta, Uwe Haberkorn, Klaus Kopka, Daniel P. Teufel	2019	49
7	Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor Nature Biotechnology ·Paul H. Holden, Vipin Asopa, Alan Robertson, Anthony R. Clarke, Sue Tyler, Gavin Bennett, Susan D. Brain, Gordon Wilcock, Shelley Allen, Stephanie K.F. Smith, David Dawbarn	1997	49
8	BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors Molecular Cancer Therapeutics ·Michael Rigby, Gavin Bennett, Liuhong Chen, Gemma Mudd, Helen Harrison, Paul Beswick, Katerine Van Rietschoten, Sophie Watcham, Heather S. Scott, Amy Brown, Peter U. Park, Carly Campbell, Eric Haines, Johanna Lahdenranta, Michael J. Skynner, Phil Jeffrey, Nicholas Keen, Kevin Lee	2022	41
9	Identification and Structure of the Nerve Growth Factor Binding Site on TrkA Biochemical and Biophysical Research Communications ·Alan Robertson, Mark J. Banfield, Shelley Allen, J. Dando, Grant Mason, Sue Tyler, Gavin Bennett, Susan D. Brain, Anthony R. Clarke, Ruth L. Naylor, Gordon Wilcock, R.L. Brady, David Dawbarn	2001	32
10	Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema Journal of Medicinal Chemistry ·Daniel P. Teufel, Gavin Bennett, Helen Harrison, Katerine Van Rietschoten, Silvia Pavan, Catherine Stace, François Le Floch, Tine Van Bergen, Elke Vermassen, Philippe Barbeaux, Tjing‐Tjing Hu, Jean H.M. Feyen, Marc Vanhove	2018	30
11	Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor British Journal of Pharmacology ·Gavin Bennett, Neil Garrett, Lara T. Diemel, Susan D. Brain, David R. Tomlinson	1998	29
12	Development of a Lc–Ms/Ms Method for the Quantification of Toxic Payload Dm1 Cleaved from Bt1718 in a Phase I Study Bioanalysis ·Catherine Gowland, Philip Berry, Julie Errington, Philip D. Jeffrey, Gavin Bennett, Lisa Godfrey, Marc Pittman, Andrew Niewiarowski, Stefan N. Symeonides, Gareth J. Veal	2021	26
13	Neurogenic oedema and vasodilatation Neuroreport ·Pamela K Towler, Gavin Bennett, P.K. Moore, Susan D. Brain	1998	17
14	Abstract 1167: Development of BT1718, a novel Bicycle Drug Conjugate for the treatment of lung cancer Cancer Research ·Gavin Bennett, Robert Lutz, Peter Park, Helen Harrison, Kevin Lee	2017	17
15	Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours Annals of Oncology ·Natalie Cook, Udai Banerji, JEFF EVANS, Andrea Biondo, Theodora Germetaki, M. Randhawa, Lisa Godfrey, Sawretse Leslie, Phil Jeffrey, Michael Rigby, Gavin Bennett, Stephen J. Blakemore, María Koehler, Andrew Niewiarowski, Marc Pittman, Stefan N. Symeonides	2019	16
16	CZ415, a Highly Selective mTOR Inhibitor Showing in Vivo Efficacy in a Collagen Induced Arthritis Model ACS Medicinal Chemistry Letters ·Andrew D. Cansfield, T. Ladduwahetty, Mihiro Sunose, Katie Ellard, Rosemary Lynch, Anthea Newton, Ann Lewis, Gavin Bennett, Nico Zinn, Douglas W. Thomson, A.J. Ruger, John T. Feutrill, Oliver Rausch, Alan P. Watt, Giovanna Bergamini	2016	14
17	Development of BT1718, a Bicycle Drug Conjugate® (BDC) targeting MT1-MMP for treatment of solid tumours European Journal of Cancer ·Gavin Bennett, Hannah Harrison, S. Campbell, Daniel P. Teufel, G. Langford, April C. Watt, Christophe Bonny	2016	14
18	BT5528-100 phase I/II study of the safety, pharmacokinetics, and preliminary clinical activity of BT5528 in patients with advanced malignancies associated with EphA2 expression. Journal of Clinical Oncology ·Johanna C. Bendell, Judy Sing-Zan Wang, Babar Bashir, Debra L. Richardson, Gavin Bennett, Carly Campbell, Meliessa Hennessy, Phil Jeffrey, Julius Kirui, Lisa Mahnke, Geoffrey I. Shapiro	2020	12
19	A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Drug Conjugate) given intravenously in patients with advanced solid tumours. Journal of Clinical Oncology ·Udai Banerji, Natalie Cook, T.R. Jeffry Evans, Irene Moreno Candilejo, Patricia Roxburgh, Claire Kelly, Narmatha Sabaratnam, Rashmi Passi, Sawretse Leslie, Sidath Katugampola, Lisa Godfrey, Neil Tremayne, Gavin Bennett, María Koehler, Gillian Langford, Stefan N. Symeonides, Marc Pittman	2018	10
20	Optimization of a series of multi-isoform PI3 kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Benjamin Perry, Rebekah E. Beevers, Gavin Bennett, George M. Buckley, Tom Crabbe, Lewis Gowers, Lynwen A. James, Kerry Jenkins, Chris M. Lock, Verity Sabin, S. Kirk Wright	2008	9

About Gavin Bennett

Gavin Bennett is a scholar working on Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging, Oncology, Pharmacology and Immunology, having authored 36 papers that have together received 2.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), Axon Guidance and Neuronal Signaling (9 papers), Peptidase Inhibition and Analysis (8 papers), HER2/EGFR in Cancer Research (8 papers), Signaling Pathways in Disease (5 papers), Glycosylation and Glycoproteins Research (5 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Protease and Inhibitor Mechanisms (4 papers). The work is most often cited by research in Developmental Neuroscience (658 citations), Cellular and Molecular Neuroscience (1.6k citations), Pathology and Forensic Medicine (706 citations), Cell Biology (543 citations) and Neurology (220 citations). Gavin Bennett has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Lawrence Moon, Reena J. Popat, Stephen B. McMahon, Elizabeth J. Bradbury, James W. Fawcett, Von R. King, Susan D. Brain, Katerine Van Rietschoten, Gemma Mudd and Liuhong Chen. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Clinical Oncology, Bioanalysis and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact